All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY557 | Anti-LGALS2 (747307) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | 747307 | Rat | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY558 | Anti-LGALS2 (CBLG1-311) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-311 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY559 | Anti-LGALS2 (13j38) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 13j38 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY560 | Anti-LGALS2 (1H6) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse | 1H6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY561 | Anti-LGALS2 (1H6-G6) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | 1H6-G6 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY563 | Anti-LGALS2 (H3F3D1) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse | H3F3D1 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2197 | Anti-LGALS2(747307) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | 747307 | Rat | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2198 | Anti-LGALS2(CBLG1-311) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-311 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY2199 | Anti-LGALS2(13j38) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 13j38 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2200 | Anti-LGALS2(1H6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse | 1H6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2201 | Anti-LGALS2(1H6-G6) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | 1H6-G6 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2203 | Anti-LGALS2(H3F3D1) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse | H3F3D1 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION